Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne Floquet

Showing results (1-10 of 96) with videos related to

Pageof 10
Sort By:
Bulletin Du Cancer|October 7, 2019
[Management of the nodal disease in vulvar cancers. The ESGO guidelines]Denis Querleu, Agnieszka Rychlik, Frédéric Guyon, et al.
Heliyon|August 28, 2023
Market opportunities seizing capability and fish farming firm performance: A dynamic managerial capability perspectiveAlbertine M Houessou, Augustin K N Aoudji, Gauthier Biaou, et al.
Bulletin Du Cancer|December 27, 2011
[Advanced endometrial carcinoma: primary debulking surgery or neoadjuvant chemotherapy?]Frédéric Guyon, Eberhard Stoeckle, Laurence Thomas, et al.
Scientifica|July 23, 2016
Dry Matter Production, Nutrient Cycled and Removed, and Soil Fertility Changes in Yam-Based Cropping Systems with Herbaceous Legumes in the Guinea-Sudan Zone of BeninRaphiou Maliki, Brice Sinsin, Anne Floquet, et al.
Oncology Letters|February 27, 2023
Surgical restaging of patients with early‑stage endometrial cancer with lymphovascular invasion does not significantly impact their survival outcomesBeatriz Navarro, Chrysoula Margioula-Siarkou, Stamatios Petousis, et al.
Bulletin Du Cancer|February 21, 2018
[Thyroid carcinoma on struma ovarii: Diagnosis and treatment]Coriolan Lebreton, Abir Al Ghuzlan, Anne Floquet, et al.
Annals of Surgical Oncology|September 21, 2013
Progress in survival outcomes in patients with advanced ovarian cancer treated by neo-adjuvant platinum/taxane-based chemotherapy and late interval debulking surgeryEberhard Stoeckle, Lionnel Bourdarias, Frédéric Guyon, et al.
Frontiers in Oncology|January 26, 2024
HE4 and CA-125 kinetics to predict outcome in patients with recurrent epithelial ovarian carcinoma: the META4 clinical trialMichel Fabbro, Pierre-Jean Lamy, Célia Touraine, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 17, 2009
Lymph node involvement in epithelial ovarian cancer: sites and risk factors in a series of 355 patientsMarion Fournier, Eberhard Stoeckle, Frédéric Guyon, et al.
Cancer Chemotherapy and Pharmacology|October 22, 2013
Pegylated liposomal doxorubicin and cyclophosphamide in early recurrent ovarian carcinoma: phase I dose-finding studyAnne Floquet, Adélaïde Doussau, Véronique Brouste, et al.
Pageof 10

Showing results (1-10 of 96) with videos related to

Sort By:
Pageof 10
Bulletin Du Cancer|October 7, 2019
[Management of the nodal disease in vulvar cancers. The ESGO guidelines]Denis Querleu, Agnieszka Rychlik, Frédéric Guyon, et al.
Heliyon|August 28, 2023
Market opportunities seizing capability and fish farming firm performance: A dynamic managerial capability perspectiveAlbertine M Houessou, Augustin K N Aoudji, Gauthier Biaou, et al.
Bulletin Du Cancer|December 27, 2011
[Advanced endometrial carcinoma: primary debulking surgery or neoadjuvant chemotherapy?]Frédéric Guyon, Eberhard Stoeckle, Laurence Thomas, et al.
Scientifica|July 23, 2016
Dry Matter Production, Nutrient Cycled and Removed, and Soil Fertility Changes in Yam-Based Cropping Systems with Herbaceous Legumes in the Guinea-Sudan Zone of BeninRaphiou Maliki, Brice Sinsin, Anne Floquet, et al.
Oncology Letters|February 27, 2023
Surgical restaging of patients with early‑stage endometrial cancer with lymphovascular invasion does not significantly impact their survival outcomesBeatriz Navarro, Chrysoula Margioula-Siarkou, Stamatios Petousis, et al.
Bulletin Du Cancer|February 21, 2018
[Thyroid carcinoma on struma ovarii: Diagnosis and treatment]Coriolan Lebreton, Abir Al Ghuzlan, Anne Floquet, et al.
Annals of Surgical Oncology|September 21, 2013
Progress in survival outcomes in patients with advanced ovarian cancer treated by neo-adjuvant platinum/taxane-based chemotherapy and late interval debulking surgeryEberhard Stoeckle, Lionnel Bourdarias, Frédéric Guyon, et al.
Frontiers in Oncology|January 26, 2024
HE4 and CA-125 kinetics to predict outcome in patients with recurrent epithelial ovarian carcinoma: the META4 clinical trialMichel Fabbro, Pierre-Jean Lamy, Célia Touraine, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 17, 2009
Lymph node involvement in epithelial ovarian cancer: sites and risk factors in a series of 355 patientsMarion Fournier, Eberhard Stoeckle, Frédéric Guyon, et al.
Cancer Chemotherapy and Pharmacology|October 22, 2013
Pegylated liposomal doxorubicin and cyclophosphamide in early recurrent ovarian carcinoma: phase I dose-finding studyAnne Floquet, Adélaïde Doussau, Véronique Brouste, et al.
Pageof 10